J2P-MC-LXBD

com.medable.lilly.j2pmclxbd

View detailed information for J2P-MC-LXBD — ratings, download counts, screenshots, pricing and developer details. See integrated SDKs and related technical data.

Total installs
4(4)
Rating
unknown
Released
September 19, 2023
Last updated
March 10, 2025
Category
Health & Fitness
Developer
Medable Inc.
Developer details
Name
Medable Inc.
E-mail
support@medable.com
Website
unknown
Country
unknown
Address
unknown
Android SDKs
J2P-MC-LXBD Header - AppWisp.com

Screenshots

J2P-MC-LXBD Screenshot 1 - AppWisp.com
J2P-MC-LXBD Screenshot 2 - AppWisp.com
J2P-MC-LXBD Screenshot 3 - AppWisp.com
J2P-MC-LXBD Screenshot 4 - AppWisp.com

Description

A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study to evaluate the efficacy and safety of 3 dose levels of BID administered LY3556050 in Adult Participants with Diabetic Peripheral Neuropathic Pain.